학술논문
Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial
Document Type
Article
Author
Nassiri, F.; Zadeh, G.; Patil, V.; Yefet, L.S.; Singh, O.; Liu, J.; Mason, W.P.; Dang, R.M.A.; Yamaguchi, T.N.; Boutros, P.; Daras, M.; Cloughesy, T.F.; Colman, H.; Kumthekar, P.U.; Chen, C.C.; Aiken, R.; Groves, M.D.; Ong, S.S.; Ramakrishna, R.; Vogelbaum, M.A.; Khagi, S.; Kaley, T.; Melear, J.M.; Peereboom, D.M.; Rodriguez, A.; Yankelevich, M.; Nair, S.G.; Puduvalli, V.K.; Fueyo, J.; Gomez-Manzano, C.; Aldape, K.; Gao, A.; López-Janeiro, Á.; de Andrea, C.E.; Alonso, M.M.; Robbins, J.; Sonabend, A.M.; Stupp, R.; Lang, F.F.
Source
In: Nature Medicine . (Nature Medicine, June 2023, 29(6):1370-1378)
Subject
Language
English
ISSN
1546170X
10788956
10788956